(Q39773769)

English

Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study (English)

1 reference

Europe PubMed Central

14 September 2017

Escherichia coli

0 references

3

object named as

Joseph L Kuti

1 reference

Europe PubMed Central

14 September 2017

David P Nicolau

5

object named as

David P Nicolau

1 reference

Europe PubMed Central

14 September 2017

author name string

Su Young Lee

1

1 reference

Europe PubMed Central

14 September 2017

Srividya Kotapati

2

1 reference

Europe PubMed Central

14 September 2017

Charles H Nightingale

4

1 reference

Europe PubMed Central

14 September 2017

publication date

23 October 2006

1 reference

Europe PubMed Central

14 September 2017

Infection Control and Hospital Epidemiology

1 reference

Europe PubMed Central

14 September 2017

27

1 reference

Europe PubMed Central

14 September 2017

11

1 reference

Europe PubMed Central

14 September 2017

1226-1232

1 reference

Europe PubMed Central

14 September 2017

Version 2000: the new beta-lactamases of Gram-negative bacteria at the dawn of the new millennium

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Clinical and Microbiologic Analysis of a Hospital's Extended‐Spectrum β‐Lactamase‐Producing Isolates Over a 2‐Year Period

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Therapeutic challenges associated with extended-spectrum, beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Determination of the in vivo pharmacodynamic profile of cefepime against extended-spectrum-beta-lactamase-producing Escherichia coli at various inocula

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

APACHE II: a severity of disease classification system

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Prevalence of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella isolates in a large community teaching hospital in Connecticut

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Plasmid-borne extended-spectrum β-lactamase in a clinical isolate of Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

The new beta-lactamases.

1 reference

https://api.crossref.org/works/10.1086%2F507962

21 January 2018

Identifiers

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39773769&oldid=2144418636"